These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 22487925)
1. Acceleration of diabetes development in CXC chemokine receptor 3 (CXCR3)-deficient NOD mice. Yamada Y; Okubo Y; Shimada A; Oikawa Y; Yamada S; Narumi S; Matsushima K; Itoh H Diabetologia; 2012 Aug; 55(8):2238-45. PubMed ID: 22487925 [TBL] [Abstract][Full Text] [Related]
2. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice. Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021 [TBL] [Abstract][Full Text] [Related]
3. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes. Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009 [TBL] [Abstract][Full Text] [Related]
5. Berretta F; Piccirillo CA; Stevenson MM Front Immunol; 2019; 10():425. PubMed ID: 30915078 [TBL] [Abstract][Full Text] [Related]
6. Antidiabetic and Immunoregulatory Activities of Extract of Lin CH; Kuo YH; Shih CC Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070 [TBL] [Abstract][Full Text] [Related]
7. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218 [TBL] [Abstract][Full Text] [Related]
8. Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model. Holohan DR; Van Gool F; Bluestone JA PLoS One; 2019; 14(10):e0217728. PubMed ID: 31647813 [TBL] [Abstract][Full Text] [Related]
9. Expression of IL-2 in β cells by AAV8 gene transfer in pre-diabetic NOD mice prevents diabetes through activation of FoxP3-positive regulatory T cells. Flores RR; Zhou L; Robbins PD Gene Ther; 2014 Aug; 21(8):715-22. PubMed ID: 24849041 [TBL] [Abstract][Full Text] [Related]
10. Gut dysbiosis promotes islet-autoimmunity by increasing T-cell attraction in islets via CXCL10 chemokine. Pöysti S; Silojärvi S; Brodnicki TC; Catterall T; Liu X; Mackin L; Luster AD; Kay TWH; Christen U; Thomas HE; Hänninen A J Autoimmun; 2023 Nov; 140():103090. PubMed ID: 37572540 [TBL] [Abstract][Full Text] [Related]
11. Low TCR signal strength induces combined expansion of Th2 and regulatory T cell populations that protect mice from the development of type 1 diabetes. Turner MS; Isse K; Fischer DK; Turnquist HR; Morel PA Diabetologia; 2014 Jul; 57(7):1428-36. PubMed ID: 24737163 [TBL] [Abstract][Full Text] [Related]
12. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25- T cells in adoptive transfer colitis. Kristensen NN; Gad M; Thomsen AR; Lu B; Gerard C; Claesson MH Inflamm Bowel Dis; 2006 May; 12(5):374-81. PubMed ID: 16670526 [TBL] [Abstract][Full Text] [Related]
13. Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Hoerning A; Koss K; Datta D; Boneschansker L; Jones CN; Wong IY; Irimia D; Calzadilla K; Benitez F; Hoyer PF; Harmon WE; Briscoe DM Eur J Immunol; 2011 Aug; 41(8):2291-302. PubMed ID: 21538345 [TBL] [Abstract][Full Text] [Related]
14. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. Montane J; Bischoff L; Soukhatcheva G; Dai DL; Hardenberg G; Levings MK; Orban PC; Kieffer TJ; Tan R; Verchere CB J Clin Invest; 2011 Aug; 121(8):3024-8. PubMed ID: 21737880 [TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Madec AM; Mallone R; Afonso G; Abou Mrad E; Mesnier A; Eljaafari A; Thivolet C Diabetologia; 2009 Jul; 52(7):1391-9. PubMed ID: 19421731 [TBL] [Abstract][Full Text] [Related]
16. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells. Mellanby RJ; Thomas D; Phillips JM; Cooke A Immunology; 2007 May; 121(1):15-28. PubMed ID: 17428252 [TBL] [Abstract][Full Text] [Related]
17. IL-33 Prevents MLD-STZ Induction of Diabetes and Attenuate Insulitis in Prediabetic NOD Mice. Pavlovic S; Petrovic I; Jovicic N; Ljujic B; Miletic Kovacevic M; Arsenijevic N; Lukic ML Front Immunol; 2018; 9():2646. PubMed ID: 30498495 [TBL] [Abstract][Full Text] [Related]
18. β-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice. Johnson MC; Garland AL; Nicolson SC; Li C; Samulski RJ; Wang B; Tisch R Diabetes; 2013 Nov; 62(11):3775-84. PubMed ID: 23884888 [TBL] [Abstract][Full Text] [Related]
19. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. Brode S; Raine T; Zaccone P; Cooke A J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572 [TBL] [Abstract][Full Text] [Related]
20. NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets. Hu C; Ding H; Li Y; Pearson JA; Zhang X; Flavell RA; Wong FS; Wen L Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11318-23. PubMed ID: 26305961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]